Benvenue's Blazer Vertebral Augmentation System now available in the U.S.

Today Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, launched the Blazer Vertebral Augmentation System for vertebral compression fractures (VCF) in the U.S. at the 2012 Society of Interventional Radiology (SIR) annual meeting. Blazer is the first clinical product in Benvenue Medical's portfolio to be commercially available in the U.S., and it is designed for spine specialists to mechanically create cavities via multiple channels in the vertebral body to direct the flow of bone cement, for greater predictability and control in vertebral augmentation procedures.                    

"Blazer is a device unlike any other that is commercially available.  It allows physicians to treat the most basic and the most complex fractures efficiently," said Francis Facchini, MD, FSIR, at the VIR Chicago in Hinsdale, IL. 

"Benvenue has developed a toolbox to treat painful VCFs as all fractures are not the same.  We believe the Blazer System is the best in class mechanical cavity creator available on the market today," said Robert Weigle, CEO of Benvenue Medical. "Blazer compliments our Kiva VCF Treatment System, currently under an IDE study named KAST.  Together, our products will be able to address the majority of patients suffering from VCFs."

Benvenue Medical is hosting a symposium in San Francisco during SIR on March 27 at 6:30 pm entitled "Growing Your Practice:  Office-Based Vertebral Augmentation" to discuss the recent reimbursement changes and how physicians can shift their practices towards the office-based environment.  An RSVP is required.                        

SOURCE Benvenue Medical, Inc.